Drug Discovery Symposium

We cordially invite you to the inaugural 2026 Drug Discovery Symposium at the Icahn School of Medicine at Mount Sinai on Friday, June 26th, 2026, in the Goldwurm Auditorium.
This one-day symposium is organized by the Department of Pharmacological Sciences in collaboration with the Drug Discovery Institute (DDI) to highlight innovative drug discovery research programs across Mount Sinai and foster collaborations across disciplines.
The program is structured around the major stages of the drug discovery pipeline: target discovery, enabling technologies, and translation development, and will feature four to five presentations per session by Mount Sinai investigators. The symposium will also feature two keynote lectures:
- Daniel Heller, PhD (Memorial Sloan Kettering Cancer Center), presenting on drug discovery and innovation, and
- Richard B. Silverman, PhD (Northwestern University), presenting on drug discovery translation and industry.

Info: Drs. Alison M. Goate, Inga Peters, Avner Schlessinger, and Daniel Wacker

Info: Drs. Min Xue, Yizhou Dong, Yi Shi, and Avi Ma'ayan

Info: "Nanotechnologies for Cancer Diagnosis and Treatment" by Daniel Heller, Ph.D., Head of the Cancer Nanotechnology Laboratory, Memorial Sloan Kettering

Info: Drs. Robert DeVita, Jian Jin, Paul Kenny, Mone Zaidi, Ron Hoffman

Info: "Novel GABA Aminotransferase and Ornithine Aminotransferase Inactivators as Potential New Treatments for Epilepsy, Pain, and Hepatocellular Carcinoma" by Richard Silverman, Ph.D., Patrick G. Ryan/Aon Professor of Chemistry, Northwestern University

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher DPS Admin